We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

128 hedge funds and large institutions have $904M invested in Sarepta Therapeutics in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70.86% more ownership

Funds ownership: 0% → 70.86% (+71%)

39% less call options, than puts

Call options by funds: $120M | Put options by funds: $196M

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.16%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$120M
Puts
$196M
Net Calls
-$75.6M
Net Calls Change
-$75.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SRPT Hedge Fund Activity: Q2 2013 in Review

128 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2013, worth a combined $904M.

Buyers outnumbered sellers: 128 funds opened new SRPT positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $904M of Sarepta Therapeutics stock for Q2 2013.
  • 128 funds opened new Sarepta Therapeutics positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.